<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ISIS</title>
    <link />
    <description>Headlines for ISIS Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Aegerion's Pricing Power Sends Shares Flying</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1452631-aegerion-s-pricing-power-sends-shares-flying.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 22 May 2013 06:29:36 GMT</pubDate>
    </item>
    <item>
      <title>Isis Pharmaceuticals' Management Presents at UBS Global Healthcare Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1447211-isis-pharmaceuticals-management-presents-at-ubs-global-healthcare-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 12:07:04 GMT</pubDate>
    </item>
    <item>
      <title>Isis Pharmaceuticals Inc (ISIS): Today's Most Compelling Stock Buy</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/isis-pharmaceuticals-inc-isis-todays-most-compelling-stock-buy-cm246978.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 17 May 2013 13:27:12 GMT</pubDate>
    </item>
    <item>
      <title>Presentation Pandemonium = 30% Pop</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/16/presentation-pandemonium-30-pop/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 16 May 2013 19:13:00 GMT</pubDate>
    </item>
    <item>
      <title>ISIS Pharmaceuticals Management Presents at Bank of America Merrill Lynch Health Care Conference (Tr</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1438351-isis-pharmaceuticals-management-presents-at-bank-of-america-merrill-lynch-health-care-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 18:26:04 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi/REGN Commence Enrollment - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99496/sanofi-regn-commence-enrollment.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 15 May 2013 17:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Isis Gets $3.5M Milestone Payment - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99373/isis-gets-$35m-milestone-payment.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 14 May 2013 15:56:01 GMT</pubDate>
    </item>
    <item>
      <title>Celgene Attains 52-Week High - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99338/celgene-attains-52-week-high.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 14 May 2013 12:43:01 GMT</pubDate>
    </item>
    <item>
      <title>1 Biotech's Surprise Dilution Decoded</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/12/1-biotechs-surprise-dilution-decoded/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 12 May 2013 14:41:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Horrendous Health-Care Stocks This Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/10/3-horrendous-health-care-stocks-this-week-27/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 10 May 2013 17:15:00 GMT</pubDate>
    </item>
    <item>
      <title>6 Superstars For Your Biotech Portfolio: John McCamant</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1424881-6-superstars-for-your-biotech-portfolio-john-mccamant.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 10 May 2013 14:57:16 GMT</pubDate>
    </item>
    <item>
      <title>Isis Pharmaceuticals Earns $3.5M from Biogen Idec</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3577093/isis-pharmaceuticals-earns-3-5m-from-biogen-idec.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 09 May 2013 16:35:06 GMT</pubDate>
    </item>
    <item>
      <title>Isis Pharmaceuticals Slides A Little Despite Strong Earnings</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1420041-isis-pharmaceuticals-slides-a-little-despite-strong-earnings.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 14:36:59 GMT</pubDate>
    </item>
    <item>
      <title>Isis Pharmaceuticals Prices 9M Share Offering at $19/Share</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3573177/isis-pharmaceuticals-prices-9m-share-offering-at-19share.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 08 May 2013 21:57:04 GMT</pubDate>
    </item>
    <item>
      <title>Isis Reports In-Line Loss - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98964/isis-reports-in-line-loss.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 08 May 2013 17:28:01 GMT</pubDate>
    </item>
    <item>
      <title>Isis Stock Falls On Unusually High Volume (ISIS)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11917961/1/isis-stock-falls-on-unusually-high-volume-isis.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 08 May 2013 16:25:00 GMT</pubDate>
    </item>
    <item>
      <title>Isis Pharmaceuticals's CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1412641-isis-pharmaceuticals-s-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 08 May 2013 01:25:06 GMT</pubDate>
    </item>
    <item>
      <title>Isis Initiates ISIS-STAT3 Study - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98882/isis-initiates-isis-stat3-study.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 07 May 2013 17:46:01 GMT</pubDate>
    </item>
    <item>
      <title>Isis Pharmaceuticals Announces Proposed Public 9M Share Offering of Common Stock</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3567615/isis-pharmaceuticals-announces-proposed-public-9m-share-offering-of-common-stock.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 07 May 2013 16:12:16 GMT</pubDate>
    </item>
    <item>
      <title>Positive Opinion on Allergan Candidate - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98760/positive-opinion-on-allergan-candidate.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 06 May 2013 16:30:01 GMT</pubDate>
    </item>
  </channel>
</rss>
